This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Dr. Sean Kevlahan, PhD
Co-founder and CEO at Nanite
Speaker

Profile

Dr. Kevlahan is an accomplished engineer and seasoned entrepreneur with over a decade of expertise in the field of cell and gene therapy. As the co-founder and CEO of Nanite, he spearheads the company's focus on AI-designed polymer nanoparticles for nucleic acid delivery. Prior to Nanite, Dr. Kevlahan established Quad Technologies, a venture later acquired by Bio-Techne. Following this acquisition, he assumed leadership roles, notably leading Bio-Techne’s cell and gene therapy division's efforts in supporting the adoptive immune cell therapies and regenerative medicine field. Holding a PhD in Chemical Engineering from Northeastern University, Dr. Kevlahan is also a co-inventor on numerous patents, underscoring his contributions to innovation in the field.

Agenda Sessions

  • Machine Learning-Driven Design of Bespoke Polymer Nanoparticles for In Vivo Gene Therapies

    2:00pm